Latest Endurant Capital Management LP Stock Portfolio

$17.44Million

About Endurant Capital Management LP and 13F Hedge Fund Stock Holdings

On 2024-02-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Endurant Capital Management LP reported an equity portfolio of $17.4 Millions as of 31 Dec, 2023. <br><br> The top stock holdings of Endurant Capital Management LP are BSX, TMO, AXNX. The fund has invested 13% of it's portfolio in BOSTON SCIENTIFIC CORP and 11.6% of portfolio in THERMO FISHER SCIENTIFIC INC. <br><br> The fund managers got completely rid off BRUKER CORP (BRKR), ASTRAZENECA PLC (AZN) and MERCK & CO INC (MRK) stocks. They significantly reduced their stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), HUMANA INC (HUM) and CENCORA INC (ABC). Endurant Capital Management LP opened new stock positions in AXONICS INC (AXNX), ICON PLC (ICLR) and LABORATORY CORP AMER HLDGS (LH).
Endurant Capital Management LP Equity Portfolio Value
Last Reported on: 14 Feb, 2024
$17.44Million
  as of Feb 14, 2024

New Buys

Ticker$ Bought
axonics inc1,547,720
icon plc1,035,750
laboratory corp amer hldgs905,523
encompass health corp858,686
pfizer inc454,594
agilent technologies inc264,157
fortrea hldgs inc243,881
qiagen nv226,661

New stocks bought by Endurant Capital Management LP

Additions

No additions were made to existing positions by Endurant Capital Management LP

Reductions

Ticker% Reduced
biomarin pharmaceutical inc-97.41
humana inc-92.88
cencora inc-91.47
cooper cos inc-91.43
sabra health care reit inc-90.18
avantor inc-89.16
orthopediatrics corp-80.92
quidelortho corp-80.76

Endurant Capital Management LP reduced stake in above stock

Sold off

Ticker$ Sold
selecta biosciences inc-480,513
ocular therapeutix inc-1,110,640
adaptimmune therapeutics plc-243,316
bluebird bio inc-765,426
bruker corp-6,932,500
astrazeneca plc-6,531,190
adapthealth corp-818,427
goodrx hldgs inc-491,443

Endurant Capital Management LP got rid off the above stocks

Endurant Capital Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Endurant Capital Management LP

$17.44MTotal Value
52.00Positions
14 Feb, 2024Last Reported
Current holdings of Current Stock Holdings of Endurant Capital Management LP, last reported on 14 Feb, 2024. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AGG
Ishares Tr

Ishares Tr

AGG
Endurant Capital Management LP's holding in Ishares Tr over time
0%0.00
$0.00
0%
decreased 100 percentsold off
ARGX
Argenx Se

Argenx Se

ARGX
Endurant Capital Management LP's holding in Argenx Se over time
0%0.00
$0.00
0%
decreased 100 percentsold off
AZN
Astrazeneca Plc

Astrazeneca Plc

AZN
Endurant Capital Management LP's holding in Astrazeneca Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off